These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 4215423)
21. Differential effects of GPA 1851 on hepatic microsomal drug metabolism dependent on dosage and time of sacrifice. Vessell ES; Lee CJ; Passananti GT; Shively CA Pharmacology; 1972; 8(4):217-21. PubMed ID: 4657973 [No Abstract] [Full Text] [Related]
22. [Effect of the lipophilic spin-labeled inhibitor of cytochrome P-450 on the activity of the microsomal system]. Subkhankulova TN; Liakhovich VV; Vaĭner LM Biokhimiia; 1987 Jul; 52(7):1186-91. PubMed ID: 3663758 [TBL] [Abstract][Full Text] [Related]
23. Polyamine effects on cytochrome P-450- and flavin-containing monooxygenase-mediated oxidation of xenobiotics. Osimitz TG; Kulkarni AP Drug Metab Dispos; 1985; 13(2):197-203. PubMed ID: 2859168 [TBL] [Abstract][Full Text] [Related]
24. A correlation between hydroxyl radical generation and ethanol oxidation by liver, lung and kidney microsomes. Winston GW; Cederbaum AI Biochem Pharmacol; 1982 Jun; 31(11):2031-7. PubMed ID: 6288048 [No Abstract] [Full Text] [Related]
25. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation. Illing HP; Kunke S; Netter KJ Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422 [No Abstract] [Full Text] [Related]
26. [The role of cytochrome p450 in metabolism of S-ethynylthiophosphates]. Vikhreva LA; Pudova TA; Godovikov NN; Kabachnik MI; Salganik RIa; Nedel'kina SV Izv Akad Nauk Ser Biol; 2000; (1):33-8. PubMed ID: 10881425 [TBL] [Abstract][Full Text] [Related]
27. Oxidation and conjugation of aflatoxins by humans and experimental animals. Guengerich FP; Raney KD; Kim DH; Shimada T; Meyer DJ; Ketterer B; Harris TM Prog Clin Biol Res; 1992; 374():157-65. PubMed ID: 1620701 [No Abstract] [Full Text] [Related]
28. Mechanism of inhibition of microsomal drug metabolism by imidazole. Hajek KK; Cook NI; Novak RF J Pharmacol Exp Ther; 1982 Oct; 223(1):97-104. PubMed ID: 7120133 [No Abstract] [Full Text] [Related]
29. Synergism of insecticidal action by inhibition of microsomal oxidation with phosphorothionates. Oppenoorth FJ; Voerman S; Welling W; Houx NW; van den Oudenweyer JW Nat New Biol; 1971 Oct; 233(40):187-8. PubMed ID: 5287091 [No Abstract] [Full Text] [Related]
30. Inhibition of in vivo and in vitro epoxidation of aldrin, and potentiation of toxicity of various insecticide chemicals by diquat in two species of fish. Krieger RI; Lee PW Arch Environ Contam Toxicol; 1973 Jul; 1(2):112-21. PubMed ID: 4204316 [No Abstract] [Full Text] [Related]
31. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members. Stearns RA; Chakravarty PK; Chen R; Chiu SH Drug Metab Dispos; 1995 Feb; 23(2):207-15. PubMed ID: 7736913 [TBL] [Abstract][Full Text] [Related]
32. Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Krause RJ; Elfarra AA Arch Biochem Biophys; 1997 Jan; 337(2):176-84. PubMed ID: 9016811 [TBL] [Abstract][Full Text] [Related]
33. Formation and binding of carbanions by cytochrome P-450 of liver microsomes. Ullrich V; Schnabel KH Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380 [No Abstract] [Full Text] [Related]
34. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Csanády GA; Guengerich FP; Bond JA Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680 [TBL] [Abstract][Full Text] [Related]
35. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes. McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831 [TBL] [Abstract][Full Text] [Related]
36. A high-performance liquid chromatographic method for the evaluation of aldrin epoxidation by cytochrome P-450 dependent monooxygenase in small liver samples. Pantaleoni GC; Palumbo G; Fanini D; Giorgi R; Carlucci G; Sponta AM J Pharm Biomed Anal; 1989; 7(6):783-8. PubMed ID: 2490781 [No Abstract] [Full Text] [Related]
37. Interaction of the imidazolone derivative GPA 1851 with hepatic microsomal drug metabolism. Zak SB; Gilleran TG; Lukas G Pharmacology; 1972; 8(4):222-31. PubMed ID: 4633044 [No Abstract] [Full Text] [Related]
38. The nature of the reverse type I (modified type II) spectral change in liver microsomes. Schenkman JB; Cinti DL; Orrenius S; Moldeus P; Kraschnitz R Biochemistry; 1972 Nov; 11(23):4243-51. PubMed ID: 5079897 [No Abstract] [Full Text] [Related]
39. Inhibition of cholesterol biosynthesis by 1-alkylimidazoles. Baggaley KH; Atkin SD; English PD; Hindley RM; Morgan B; Green J Biochem Pharmacol; 1975 Oct; 24(20):1902-3. PubMed ID: 1191407 [No Abstract] [Full Text] [Related]
40. Rat liver cytochrome P-450 isozymes as catalysts of aldrin epoxidation in reconstituted monooxygenase systems and microsomes. Wolff T; Guengerich FP Biochem Pharmacol; 1987 Aug; 36(16):2581-8. PubMed ID: 3606656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]